1. Home
  2. SRRK vs BDC Comparison

SRRK vs BDC Comparison

Compare SRRK & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$49.35

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$122.25

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
BDC
Founded
2012
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
SRRK
BDC
Price
$49.35
$122.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
2
Target Price
$56.17
$162.50
AVG Volume (30 Days)
1.1M
543.4K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
0.16%
EPS Growth
N/A
23.13
EPS
N/A
1.30
Revenue
N/A
$2,715,194,000.00
Revenue This Year
N/A
$8.91
Revenue Next Year
$534.24
$4.70
P/E Ratio
N/A
$94.82
Revenue Growth
N/A
10.33
52 Week Low
$27.07
$101.00
52 Week High
$52.19
$159.99

Technical Indicators

Market Signals
Indicator
SRRK
BDC
Relative Strength Index (RSI) 59.72 63.55
Support Level $45.46 $106.31
Resistance Level $51.55 $122.61
Average True Range (ATR) 2.07 5.04
MACD 0.38 2.08
Stochastic Oscillator 92.50 73.81

Price Performance

Historical Comparison
SRRK
BDC

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

Share on Social Networks: